Home > Journals > Minerva Urology and Nephrology > Past Issues > Minerva Urology and Nephrology 2021 August;73(4) > Minerva Urology and Nephrology 2021 August;73(4):424-7

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

MINERVA OPINION EDITORIAL   

Minerva Urology and Nephrology 2021 August;73(4):424-7

DOI: 10.23736/S2724-6051.21.04592-4

Copyright © 2021 EDIZIONI MINERVA MEDICA

language: English

Potential utility of a 4-marker immunohistochemistry panel to predict response to cisplatin-based neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer: a single-center preliminary experience

Simone MORSELLI 1, 2 , Riccardo CAMPI 1, 2, Mauro GACCI 1, 2, Arcangelo SEBASTIANELLI 1, 2, Caterina FATTORINI 3, Donata VILLARI 1, 2, Marco CARINI 2, 4, Andrea MINERVINI 2, 4, Sergio SERNI 1, 2, Maria R. RASPOLLINI 3

1 Unit of Urological Robotic Surgery and Renal Transplantation, Careggi Hospital, University of Florence, Florence, Italy; 2 Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; 3 Department of Histopathology and Molecular Diagnostics, Careggi Hospital, University of Florence, Florence, Italy; 4 Unit of Urological Oncologic Minimally-Invasive Robotic Surgery and Andrology, Careggi Hospital, University of Florence, Florence, Italy



top of page